Menopausal symptoms score. Menopausal and female climacteric states
Conditions
Interventions
Intervention 1: For the intervention group, each participant will be given a 50-gram tube with an applicator, instructions for use, and a side effects registration form for use for 12 weeks. The metho
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: At least one year has passed since the last menstrual period or having a hormone test with an FSH level greater than 40 international units Obtaining a score of 5 or more from the MRS questionnaire Age between 45 and 65 years Being married Absence or history of uterine and breast cancer
Exclusion criteria
Exclusion criteria: Having uterine bleeding or spotting with an unknown cause Vaginal infection requires treatment Abnormalities of the genital system Under sex hormone therapy within 8 weeks before the study Use of vaginal drugs or any lubricants at least 15 days before the study Smoking (alcohol, cigarettes, hookah) Body mass index more than 30 kg/m2 Cholestatic liver disorders, severe kidney failure, acute thromboembolism and high blood pressure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hot flushes. Timepoint: before the start of the study, 2, 6 and 12 weeks after the intervention. Method of measurement: Ask the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Susan Heydarpour
Kermanshah University of Medical Sciences
Outcome results
None listed